Straight Path Wealth Management »

Lexicon Pharmaceuticals shares owned by Straight Path Wealth Management

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Straight Path Wealth Management from 13F filings

Historical chart of Straight Path Wealth Management investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Straight Path Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Straight Path Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $85k 63k 1.35
2025-06-30 $59k 63k 0.95
2025-03-31 $29k 63k 0.46

More positions owned by Straight Path Wealth Management

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Tesla Motors Call Option (TSLA)
BP Sponsored Adr (BP)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Global Core Plus (DFGP)
Ishares Tr Msci Usa Mmentm (MTUM)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Ishares Tr Msci Intl Moment (IMTM)
B. Riley Financial Put Option (RILY)
Invesco Exch Trd Slf Idx Invsco Blsh 28 (BSCS)
Invesco Exch Trd Slf Idx Bulshs 2027 Cb (BSCR)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Byrna Technologies Com New (BYRN)
Invesco Exch Trd Slf Idx Bulshs 2025 Cb (BSCP)
Dimensional Etf Trust Us Real Estate E (DFAR)

View all positions for Straight Path Wealth Management

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
FMR
Vanguard Group
Millennium Management
BlackRock
Citadel Advisors
Sessa Capital IM
Atlantic Trust
Geode Capital Management
Caption Management
Susquehanna International
GSA Capital Partners
Charles Schwab Investment Management
State Street Corporation

View all funds holding Lexicon Pharmaceuticals